Ventyx Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -316 | -408 | ||
EBITDA | -32,103 | -38,243 | -35,396 | -41,360 |
EBIT | -32,418 | -38,552 | -35,712 | -41,768 |
Net Income | -29,351 | -35,249 | -31,950 | -38,572 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,255 | -35,461 | -24,598 | -47,800 |
Cash | 27,260 | 61,765 | 40,925 | 141,898 |
Basic Shares | 68,478 | 70,667 | 70,554 | 61,829 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -941 | -470 | -30 | |
EBITDA | -148,450 | -207,836 | -107,956 | -67,117 |
EBIT | -207,994 | -108,426 | -67,147 | |
Net Income | -135,122 | -192,962 | -107,956 | -78,366 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -5,930 | 70,547 | ||
Free Cash Flow | -131,114 | -167,036 | -99,046 | -38,912 |
Cash | 27,260 | 51,579 | 64,819 | 70,791 |
Basic Shares | 68,478 | 58,542 | 52,471 | 50,408 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.41 |
2024-09-30 | -$0.50 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.62 |
